Name (Synonyms) | Correlation | |
---|---|---|
drug1354 | Lopinavir Wiki | 1.00 |
drug1176 | Imaging by thoracic scanner Wiki | 1.00 |
drug2840 | hydroxychloroquine Wiki | 0.50 |
drug262 | Azithromycin Wiki | 0.17 |
There is one clinical trial.
This study seeks to determine whether dual or quadruple therapy is more effective in treating COVID-19.
Description: Time to reduced symptoms in each treatment group as indicated by NEWS scores, which rate patient status based on a zero to three scale for 8 parameters. These values are added up to create the NEWS score. The lower the NEWS score, the better the patient's clinical condition. Zero is the lowest possible score, whereas 7 or greater represents a high degree of clinical risk.
Measure: Efficacy of Treatment by Reduced Symptoms NEWS (National Early Warning System) scores Time: 6 monthsDescription: Time to non-infectivity as measured by PCR testing
Measure: Efficacy of Treatment by Time to Non-Infectivity Time: 10 daysDescription: Patient symptoms will be recorded using the NEWS system, which rates patient status based on a zero to three scale for 8 parameters. These values are added up to create the NEWS score. The lower the NEWS score, the better the patient's clinical condition. Zero is the lowest possible score, whereas 7 or greater represents a high degree of clinical risk.
Measure: Safety of Dual Therapy as Measured by Symptoms rated on the NEWS (National Early Warning System) sores Time: 6 monthsDescription: Patient symptoms will be recorded using the NEWS system, which rates patient status based on a zero to three scale for 8 parameters. These values are added up to create the NEWS score. The lower the NEWS score, the better the patient's clinical condition. Zero is the lowest possible score, whereas 7 or greater represents a high degree of clinical risk.
Measure: Safety of Quadruple Therapy as Measured by Symptoms rated on the NEWS (National Early Warning System) scores. Time: 6 monthsDescription: Changes in blood parameters measured in a Complete Blood Count (CBC).
Measure: Safety of Dual Therapy as Measured by Complete Blood Count Time: 6 monthsDescription: Changes in blood parameters measured in a Complete Metabolic Panel.
Measure: Safety of Quadruple Therapy as Measured by Complete Blood Count Time: 6 monthsDescription: Changes in serum albumin levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel -Albumin Time: 6 monthsDescription: Changes in serum albumin levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Albumin Time: 6 monthsDescription: Changes in serum albumin/globulin ratio
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - A/G Ratio Time: 6 monthsDescription: Changes in serum albumin/globulin ratio
Measure: Safety of Dual Therapy as Measured by Metabolic Panel A/G Ratio Time: 6 monthsDescription: Changes in serum alkaline phosphatase levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Alkaline Phosphatase Time: 6 monthsDescription: Changes in serum alkaline phosphatase levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel Alkaline Phosphatase Time: 6 monthsDescription: Changes in serum AST levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - AST Time: 6 monthsDescription: Changes in serum AST levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - AST Time: 6 monthsDescription: Changes in serum ALT levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - ALT Time: 6 monthsDescription: Changes in serum ALT levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel ALT Time: 6 monthsDescription: Changes in serum BUN/Creatinine Ratio
Measure: Safety of Dual Therapy as Measured by Metabolic Panel BUN/Creatinine Ratio Time: 6 monthsDescription: Changes in serum BUN/Creatinine Ratio
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel BUN/Creatinine Ratio Time: 6 monthsDescription: Changes in serum Blood Urea Nitrogen levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - BUN Time: 6 monthsDescription: Changes in serum Blood Urea Nitrogen levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - BUN Time: 6 monthsDescription: Changes in serum calcium levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - Calcium Time: 6 monthsDescription: Changes in serum calcium levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Calcium Time: 6 monthsDescription: Changes in serum carbon dioxide levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Carbon Dioxide Time: 6 monthsDescription: Changes in serum carbon dioxide levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - Carbon Dioxide Time: 6 monthsDescription: Changes in serum chloride levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - Chloride Time: 6 monthsDescription: Changes in serum chloride levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Chloride Time: 6 monthsDescription: Changes in serum creatinine levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Creatinine Time: 6 monthsDescription: Changes in serum creatinine levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - Creatinine Time: 6 monthsDescription: Changes in serum globulin levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - Globulin Time: 6 monthsDescription: Changes in serum globulin levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Globulin Time: 6 monthsDescription: Changes in blood glucose levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Glucose Time: 6 monthsDescription: Changes in blood glucose levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - Glucose Time: 6 monthsDescription: Changes in blood potassium levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - Potassium Time: 6 monthsDescription: Changes in blood potassium levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Potassium Time: 6 monthsDescription: Changes in serum total bilirubin levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Total Bilirubin Time: 6 monthsDescription: Changes in serum total bilirubin levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - Total Bilirubin Time: 6 monthsDescription: Changes in serum total protein levels
Measure: Safety of Dual Therapy as Measured by Metabolic Panel - Total Protein Time: 6 monthsDescription: Changes in serum total protein levels
Measure: Safety of Quadruple Therapy as Measured by Metabolic Panel - Total Protein Time: 6 monthsDescription: Presence or absence of treatment related serious adverse events Grade III or higher
Measure: Safety of Dual Therapy as Measured by Treatment Related SAE Time: 6 monthsDescription: Presence or absence of treatment related serious adverse events Grade III or higher
Measure: Safety of Quadruple Therapy as Measured by Treatment Related SAE Time: 6 months